Abstract:OBJECTIVE:To investigate the correlation of the apparent diffusion coefficient (ADC) on diffusion-weighted MRI (DWI) with the prognosis of locally advanced gastric carcinoma after neoadjuvant chemotherapy (NACT).METHODS:Patients with locally advanced gastric carcinoma undergoing NACT in our hospital from November 2010 to September 2011 were enrolled in this prospective study. MRI examinations were performed before and after NACT. ADCs of the whole lesion (ADCentire) and high signal area on DWI (ADCmin) were calculated, and the cancer thickness on T2-weighted images was measured. All the patients were divided into long-term survival group and poor prognosis group, according to the 3-year survival status. The pre-therapy baseline values and early percentage changes (%delta) of the above parameters were compared between the two groups. Receiver operating characteristics (ROC) curves were employed to compare the performance of the above parameters in the discrimination of different prognosis groups.RESULTS:A total of 24 patients were enrolled in the study. There were 14 patients of long-term survival group and 10 patients of poor prognosis group. No statistical difference in baseline ADCmin and ADCentire was shown between long-term survival group and poor prognosis group [ADCmin: (1.17 ± 0.23)×10⁻³ mm²/s vs. (1.23 ± 0.27) × 10⁻³ mm²/s, P>0.05; ADCentire: (1.43 ± 0.20) × 10⁻³ mm²/s vs. (1.50 ± 0.24) × 10⁻³ mm²/s, P>0.05]. The % ΔADCmin and % ΔADCentire were both higher in long-term survival group than those in poor prognosis group (% ΔADCmin: 21% vs. 5%, P=0.06; % ΔADCentire: 23% vs. 1%, P=0.02). Through ROC curves, the AUCs for pre-therapy cancer thickness, ADCmin and ADCentire were 0.693, 0.543 and 0.600 respectively, and AUCs for % deltathickness, % ΔADCmin and % ΔADCentire were 0.532, 0.729 and 0.779 respectively, in the differentiation of prognosis. Using % ΔADC≥15% to predict long-term survival, the positive predictive value (PPV) for % ΔADCmin was 81.8% and % ΔADCentire was 83.3%. Using % ΔADC ≤ 10% to predict poor prognosis, the PPV for % ΔADCmin was 63.6% and % ΔADCentire was 70.0%.CONCLUSIONS:The change of ADC after NACT of gastric carcinoma is correlated with long-term prognosis. The significantly increased ADC is prone to signify long-term survival. ADCentire is better than ADCmin in the prognosis prediction.

Application of 3.0T magnetic resonance diffusion weighted imaging in the advanced gastric cancer

Reduced Field-of-view Diffusion-Weighted Imaging (DWI) in Patients with Gastric Cancer

Application of 3.0T-MRI DWI in evaluating the efficacy of synchronous radiotherapy and chemotherapy for advanced lung cancer

The diagonstic value of the 3.0 T DW-MRI in the different degrees differentiation of gastric cancer

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Diffusion-weighted Magnetic Resonance Imaging in the Depiction of Gastric Cancer: Initial Experience

Value of Diffusion Weighted Imaging in Diagnosis and Treatment of Gastric Cancer

Diagnostic Value of Magnetic Resonance Diffusion Weighted Imaging for Metastatic Lymph Nodes in Patients with Gastric Cancer

[Correlation of Diffusion Weighted MR Imaging with the Prognosis of Local Advanced Gastric Carcinoma after Neoadjuvant Chemotherapy].

Preoperative T staging of gastric cancer: comparison of diffusion- and T2-weighted magnetic resonance imaging.

Diffusion-weighted MR imaging of gastric cancer:study of parallel imaging combined with separate breath-holds and multi-NEX technique

The application value of 3.0T MRI molecular imaging of aquaporins in pancreatic cancer

The Applied Research on Respiratory-triggered Diffusion-weighted MR Imaging of Pancreatic Carcinoma at 3.0T

The Diagnostic Value of Diffusion Weighted Imaging and ADC Values in the Determination of Lymph Node Metastases of Gastric Cancer

Application of 3.0T MRI in Preoperative T Staging of Advanced Gastric Cancer

Application of 3.0T MRI in the preoperative assessment of rectal carcinoma

MR diffusion weighted imaging of gastric cancer:b-value determination and comparison with routine sequences

Added Value of Diffusion-Weighted Mr Imaging to T2-Weighted and Dynamic Contrast-Enhanced Mr Imaging in T Staging of Gastric Cancer

Discrimination of Metastatic Lymph Nodes in Patients with Gastric Carcinoma Using Diffusion-Weighted Imaging

Applicable Apparent Diffusion Coefficient of an Orthotopic Mouse Model of Gastric Cancer by Improved Clinical MRI Diffusion Weighted Imaging.

Value of Diffusion-Weighted Imaging and Apparent Diffusion Coefficient in Diagnosis of Malignant Lymphoma at 3.0T MRI